David Livermore joins the advisory board of BioVersys

“Our already strong scientific advisory board is receiving a further boost by welcoming Professor David Livermore and we are proud that our technology and our team were able to attracted him to BioVersys.” says Dr. Marcel Tigges, CSO of BioVersys.

David Livermore worked at the London Hospital Medical College from 1980 until 1997 when he joined the Health Protection Agency (now Public Health England), becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory in 1998. In October 2011 he became Professor of Medical Microbiology at the University of East Anglia but with 30% of this time supplied back to Public Health England as its Lead on Antibiotic Resistance.

He has broad interests on the evolution and dissemination of antibiotic resistance and its relationship to antibiotic prescribing. Prof Livermore sits on the British Society for Antimicrobial Chemotherapy's working parties on resistance surveillance, multi-resistant pathogens and susceptibility testing and on its Antibiotic Action advisory board. He also is a member of the UK Government's Antimicrobial Resistance & Healthcare Infections Advisory Committee. He publishes and speaks widely on resistance and has edited for several journals.